Save on Acid Reflux Medications in California
Compare Acid Reflux Medications prices across California pharmacies. Save up to 64% — no insurance required.
Top Acid Reflux Medications for California Residents
Omeprazole (Prilosec)
Pantoprazole (Protonix)
Esomeprazole (Nexium)
Dexlansoprazole (Dexilant)
Famotidine (Pepcid)
California Prescription Assistance Programs
Medi-Cal Rx
Comprehensive outpatient prescription drug coverage for Medi-Cal beneficiaries, including generic and brand-name medications on the formulary.
Eligibility: California Medicaid (Medi-Cal) enrollees. Income limits vary by category; generally up to 138% FPL for adults.
GHPP (Genetically Handicapped Persons Program)
Prescription drugs and medical services for individuals with covered genetic conditions including cystic fibrosis, hemophilia, PKU, sickle cell disease, and others.
Eligibility: California residents with a diagnosed covered genetic condition; income-based co-pays apply.
Frequently Asked Questions
Is omeprazole cheap as a generic?
Generic omeprazole is available OTC for around $10–$15/month and prescription generics are even cheaper per-unit via ScriptUnlock bids — often under $10 for a 30-day supply.
Should I use a PPI or H2 blocker for acid reflux?
PPIs are more potent and appropriate for GERD; H2 blockers like famotidine work well for occasional reflux. Your doctor or pharmacist can guide the choice — ScriptUnlock helps with pricing for either.
How much can I save switching from Nexium to esomeprazole?
Brand Nexium can cost $200–$300/month without insurance; generic esomeprazole is typically $20–$40. ScriptUnlock bids make that comparison instant and actionable.
Can I use ScriptUnlock for compounded omeprazole suspension?
Yes. Compounded omeprazole for pediatric or NG-tube patients can be sourced through ScriptUnlock compounding pharmacy partners.
Is long-term PPI use safe?
PPIs are generally safe for appropriate indications but should be used at the lowest effective dose. Discuss duration and tapering with your prescriber — ScriptUnlock helps with the cost, not the clinical decision.